We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 731 results
  1. Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database

    Background

    Semaglutide, liraglutide and tirzepatide are glucagon-like peptide-1 (GLP-1) receptor agonists that are effective for weight reduction....

    Mansour Tobaiqy, Hajer Elkout in International Journal of Clinical Pharmacy
    Article Open access 24 January 2024
  2. Adverse events of clenbuterol among athletes: a systematic review of case reports and case series

    Clenbuterol is a potent beta-2 agonist widely misused by professional athletes and bodybuilders. Information on clenbuterol associated adverse events...

    Sweta Kumari, Biplab Pal, ... Devesh Tewari in International Journal of Legal Medicine
    Article 17 April 2023
  3. Endoscopic full-thickness resection for upper gastrointestinal tract lesions: a systematic review and meta-analysis

    Introduction

    Endoscopic full-thickness resection (EFTR) is used to resect difficult superficial mucosal lesions and sub-epithelial lesions (SELs). We...

    Mohamed Abdallah, Gaurav Suryawanshi, ... Mohammad Bilal in Surgical Endoscopy
    Article 14 December 2022
  4. Effectiveness and safety of mexiletine versus placebo in patients with myotonia: a systematic review and meta-analysis

    Background

    The rare nature of dystrophic and non-dystrophic myotonia has limited the available evidence on the efficacy of mexiletine as a potential...

    Abdelrahman Mohammed Elettreby, Ahmed Abdullah Abo Elnaga, ... Gehad Magdy Alderbi in Neurological Sciences
    Article 26 February 2024
  5. Cancer immunotherapy–related adverse events: causes and challenges

    Despite the success and ongoing promise of monoclonal antibody–targeted immune checkpoint inhibitor immunotherapy of advanced malignancies, in...

    Ada G. Blidner, Jennifer Choi, ... Ronald Anderson in Supportive Care in Cancer
    Article 28 August 2020
  6. Safety of Chronic Simvastatin Treatment in Patients with Decompensated Cirrhosis: Many Adverse Events but No Liver Injury

    Background

    The high mortality rate of decompensated cirrhosis underlines the need for new treatments. Experimental models of cirrhosis and its...

    Alberto E. Muñoz, Florencia Pollarsky, ... Gustavo Romero in Digestive Diseases and Sciences
    Article 09 October 2020
  7. Evaluating the effectiveness and safety of various Tirzepatide dosages in the management of Type 2 diabetes mellitus: a network meta-analysis of randomized controlled trials

    Purpose

    Excess body fat, insulin resistance, and abnormal lipid levels signal type 2 diabetes mellitus (DM2). Globally, 536.6 million people suffer...

    Hussain Sohail Rangwala, Hareer Fatima, ... Syed Raza Abbas in Journal of Diabetes & Metabolic Disorders
    Article 25 March 2024
  8. “Side effects--part of the package”: a mixed methods approach to study adverse events among patients being programmatically treated for DR-TB in Gujarat, India

    Background

    High rates of Adverse Events (AEs) during treatment is one of the leading causes of unsuccessful treatment outcomes among patients with...

    Arjunkumar Jakasania, Kalpita Shringarpure, ... Soundappan Kathirvel in BMC Infectious Diseases
    Article Open access 02 December 2020
  9. Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-α inhibitor initiation in children in Spain

    Tumor-necrosis-factor-α inhibitors (anti-TNF-α) are associated with an increased risk of tuberculosis (TB) disease, primarily due to reactivation of...

    Joan Calzada-Hernández, Jordi Anton, ... Antoni Noguera-Julian in European Journal of Pediatrics
    Article Open access 05 November 2022
  10. Evaluation of efficacy and safety profile of tadalafil 5 mg daily dose in the tablet form versus oral dispersible film in men with mild-to-moderate erectile dysfunction: a comparative placebo-controlled study

    Purpose

    We aimed to compare the efficacy, safety, and compliance of tadalafil 5 mg daily dose in the tablet form versus oral dispersible film (ODF) in...

    Ahmad T. Motawi, Sameh Fayek GamalEl Din, ... Ibrahim Fahmy in International Urology and Nephrology
    Article Open access 04 March 2024
  11. Association Between Adverse Childhood Experiences and Oral Health in Adulthood: A Systematic Sco** Review

    Purpose

    A gap remains in the synthesis of studies focusing on the long-term effects of Adverse Childhood Experiences (ACEs) on the oral health of...

    Letícia R. M. Sartori, Daniela H. Pereira, ... Marcos B. Correa in Journal of Family Violence
    Article 24 November 2022
  12. Analysis of Surgical Mortalities Using the Fishbone Model for Quality Improvement in Surgical Disciplines

    Background

    The healthcare industry is complex and prone to the occurrence of preventable patient safety incidents. Most serious patient safety events...

    M. S. Moeng, T. E. Luvhengo in World Journal of Surgery
    Article 04 February 2022
  13. The cytokeratin 17 expression in primary ovarian tumors has diagnostic but not prognostic significance

    We assessed the value of cytokeratin 17 (CK17) expression for the differential diagnosis between primary ovarian mucinous tumors and metastases from...

    Pavel Dundr, Barbora Bazalová, ... Ivana Stružinská in Virchows Archiv
    Article 13 May 2022
  14. Efficacy and gastrointestinal tolerability of methotrexate in late-onset rheumatoid arthritis patients: a prospective cohort study

    Background

    The proportion of the late-onset forms of disease is growing in rheumatoid arthritis (RA) population. Concerns about comorbidities and drug...

    Esra Dilsat Bayrak, Ilknur Aktas in Egyptian Rheumatology and Rehabilitation
    Article Open access 13 February 2023
  15. Study the response of Qurevo (ombitasvir, paritaprevir, and ritonavir) in end-stage renal disease patients with hepatitis C virus

    Background

    Out of the 185 million people infected with hepatitis C virus (HCV) worldwide according to the World Health Organization (WHO), Egypt had...

    Howayda Abd Elhameed Elshinnawy, Iman Ibrahim Sarhan, ... Cherry Reda Kamel in Egyptian Liver Journal
    Article Open access 14 June 2022
  16. Efficacy and safety of intravenous immunoglobulin therapy in systemic sclerosis: a systematic review

    Background and objective

    Systemic sclerosis (SSc) is a highly heterogeneous disease whose treatment is based mainly on immunosuppressants,...

    Sandra Garrote-Corral, Diana Botello Corzo, ... Loreto Carmona in Rheumatology International
    Article 15 May 2024
  17. Omentopexy Effect on the Upper Gastrointestinal Symptoms and the Esophagogastroduodenoscopy Findings in Patients Undergoing Sleeve Gastrectomy

    Background

    Laparoscopic sleeve gastrectomy (LSG) has gained acceptance worldwide. However, SG has its own complications that need a specialized...

    Amir K. Abosayed, Mohamed Saber Mostafa in Obesity Surgery
    Article Open access 23 March 2022
  18. Day of Surgery Admission (DOSA): Thirteen Years’ Experience in a Resource-Limited Hospital in East Sudan-Kassala

    With the growing need for health services, proper bed capacity management is mandatory to avoid patient rejection or cancellation of a procedure....

    Abdel Latif K. Elnaim, Mohammed Mahmoud Ali Osheik, ... Rawah Suliman Mohamed Ahmed in Indian Journal of Surgery
    Article 10 February 2024
  19. A Comparative View of Reported Adverse Effects of Statins in Social Media, Regulatory Data, Drug Information Databases and Systematic Reviews

    Introduction

    There are few studies assessing how data on adverse drug events from consumers on social media compare with other sources.

    ...
    Su Golder, Karen Smith, ... Graciela Gonzalez-Hernandez in Drug Safety
    Article Open access 01 October 2020
  20. Efficacy and safety of gut microbiota-based therapies in autoimmune and rheumatic diseases: a systematic review and meta-analysis of 80 randomized controlled trials

    Background

    Previous randomized controlled trials (RCTs) suggested that gut microbiota-based therapies may be effective in treating autoimmune...

    Liuting Zeng, Kailin Yang, ... Lingyun Sun in BMC Medicine
    Article Open access 13 March 2024
Did you find what you were looking for? Share feedback.